Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced that at the 2025 ESMO Asia Congress, updated results from the pivotal Phase III HARMONi-6 study (AK112-306) were shared in an oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback